MENU
+Compare
BMED
ETF ticker: NYSE ARCA
AS OF
Feb 3, 03:29 PM (EDT)
Price
$31.11
Change
+$3.32 (+11.95%)
Net Assets
9.94M

BMED stock forecast, quote, news & analysis

The investment seeks to maximize total return... Show more

Category: #Health
BMED
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
These past five trading days, the ETF lost 0.00% with an average daily volume of 0 shares traded.The ETF tracked a drawdown of 0% for this period.
Interact to see
Advertisement
A.I.Advisor
a Summary for BMED with price predictions
Feb 02, 2026

BMED in +0.44% Uptrend, rising for three consecutive days on January 27, 2026

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where BMED advanced for three days, in of 300 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on February 02, 2026. You may want to consider a long position or call options on BMED as a result. In of 90 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 269 cases where BMED Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for BMED moved out of overbought territory on January 23, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 35 similar instances where the indicator moved out of overbought territory. In of the 35 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 63 cases where BMED's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for BMED turned negative on January 28, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BMED declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

BMED broke above its upper Bollinger Band on January 07, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Johnson & Johnson (NYSE:JNJ), ABBVIE (NYSE:ABBV), Abbott Laboratories (NYSE:ABT), Amgen (NASDAQ:AMGN), Gilead Sciences (NASDAQ:GILD), Intuitive Surgical (NASDAQ:ISRG), Pfizer (NYSE:PFE), Boston Scientific Corp (NYSE:BSX), Medtronic plc (NYSE:MDT), Bristol-Myers Squibb Co (NYSE:BMY).

Industry description

The investment seeks to maximize total return. Under normal market conditions, the fund will invest at least 80% of its net assets plus any borrowings for investment purposes in equity securities of companies principally engaged in the health sciences group of industries. While the fund will invest primarily in companies providing products and services for human health, it may also invest in companies whose products or services relate to the growth or survival of animals and plants.

Market Cap

The average market capitalization across the iShares Health Innovation Active ETF ETF is 38.04B. The market cap for tickers in the group ranges from 57.88M to 555.94B. JNJ holds the highest valuation in this group at 555.94B. The lowest valued company is TCRX at 57.88M.

High and low price notable news

The average weekly price growth across all stocks in the iShares Health Innovation Active ETF ETF was 31%. For the same ETF, the average monthly price growth was 43%, and the average quarterly price growth was 418%. ALLO experienced the highest price growth at 24%, while RGNX experienced the biggest fall at -22%.

Volume

The average weekly volume growth across all stocks in the iShares Health Innovation Active ETF ETF was 3%. For the same stocks of the ETF, the average monthly volume growth was 29% and the average quarterly volume growth was -22%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 59
P/E Growth Rating: 70
Price Growth Rating: 49
SMR Rating: 76
Profit Risk Rating: 80
Seasonality Score: -30 (-100 ... +100)
View a ticker or compare two or three
BMED
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category Health

Profile
Fundamentals
Details
Category
Health
Address
BlackRock ETF Trust100 BELLEVUE PARKWAY
Phone
N/A
Web
www.blackrock.com